Pro Dex Inc (PDEX) stock
PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/3012% below fair value
$61.93−2.55 (-3.95%)
Close on Nov 17, 2026Market cap $198.18MP/E 17.1Yield –
Pro Dex revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pro Dex's revenue for the twelve months ending Sep 30, 2026 was $79.58M, up 13.3% year over year. For fiscal 2026 it was $77.55M, up 16.5% from the year before. Over ten years it grew 15.0% a year on average. The highest annual figure on record is $77.55M in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $77.55M | +16.5% |
| FY2025 | Jun 30, 2025 | $66.59M | +23.7% |
| FY2024 | Jun 30, 2024 | $53.84M | +16.8% |
| FY2023 | Jun 30, 2023 | $46.09M | +9.6% |
| FY2022 | Jun 30, 2022 | $42.04M | +10.5% |
| FY2021 | Jun 30, 2021 | $38.03M | +9.2% |
| FY2020 | Jun 30, 2020 | $34.83M | +28.2% |
| FY2019 | Jun 30, 2019 | $27.17M | +21.0% |
| FY2018 | Jun 30, 2018 | $22.47M | +2.4% |
| FY2017 | Jun 30, 2017 | $21.94M | +14.4% |
| FY2016 | Jun 30, 2016 | $19.19M | +43.4% |
| FY2015 | Jun 30, 2015 | $13.38M | +23.8% |
| FY2014 | Jun 30, 2014 | $10.81M | -11.7% |
| FY2013 | Jun 30, 2013 | $12.25M | +82.5% |
| FY2012 | Jun 30, 2012 | $6.71M | -72.1% |
| FY2011 | Jun 30, 2011 | $24.06M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $20.56M | +11.0% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $20.41M | +16.6% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $19.95M | +14.6% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $18.66M | +11.1% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $18.53M | +24.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $17.49M | +16.4% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $17.41M | +21.8% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $16.79M | +33.4% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $14.89M | +24.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $15.03M | +41.2% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $14.29M | +9.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $12.59M | +11.6% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $11.94M | +7.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $10.64M | -15.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $13.08M | +41.2% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $11.28M | +10.9% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $11.09M | +11.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $12.62M | +33.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $9.27M | -21.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $10.17M | +23.1% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $9.99M | +16.3% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $9.44M | -15.2% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $11.74M | +38.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $8.27M | +3.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $8.59M | +18.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $11.12M | +58.8% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $8.51M | +24.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $7.96M | +24.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $7.24M | +4.7% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $7.00M | +12.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $6.85M | +24.8% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $6.40M | +15.1% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $6.92M | +34.0% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $6.25M | +11.6% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $5.49M | -17.0% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $5.56M | +20.9% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $5.16M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $5.60M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $6.62M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $4.60M | – |
See a number that looks wrong?